Literature DB >> 15006410

Highly potent and long-acting trimeric and tetrameric inhibitors of influenza virus neuraminidase.

Keith G Watson1, Rachel Cameron, Rob J Fenton, David Gower, Stephanie Hamilton, Betty Jin, Guy Y Krippner, Angela Luttick, Darryl McConnell, Simon J F MacDonald, Andy M Mason, Van Nguyen, Simon P Tucker, Wen-Yang Wu.   

Abstract

A set of trimeric and tetrameric derivatives 6-11 of the influenza virus neuraminidase inhibitor zanamivir 1 have been synthesized by coupling a common monomeric zanamivir derivative 3 onto various multimeric carboxylic acid core groups. These discrete multimeric compounds are all significantly more antiviral than zanamivir and also show outstanding long-lasting protective activity when tested in mouse influenza infectivity experiments.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15006410     DOI: 10.1016/j.bmcl.2003.09.102

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  8 in total

Review 1.  Recent progress in structure-based anti-influenza drug design.

Authors:  Juan Du; Timothy A Cross; Huan-Xiang Zhou
Journal:  Drug Discov Today       Date:  2012-06-13       Impact factor: 7.851

2.  A zanamivir dimer with prophylactic and enhanced therapeutic activity against influenza viruses.

Authors:  E Bart Tarbet; Stephanie Hamilton; Almut H Vollmer; Angela Luttick; Wy Ching Ng; Melinda Pryor; Brett L Hurst; Simon Crawford; Donald F Smee; Simon P Tucker
Journal:  J Antimicrob Chemother       Date:  2014-04-28       Impact factor: 5.790

3.  A chemically programmed antibody is a long-lasting and potent inhibitor of influenza neuraminidase.

Authors:  Masahiko Hayakawa; Narihiro Toda; Nancy Carrillo; Natalie J Thornburg; James E Crowe; Carlos F Barbas
Journal:  Chembiochem       Date:  2012-09-10       Impact factor: 3.164

4.  Synthesis of C-4 and C-7 triazole analogs of zanamivir as multivalent sialic acid containing scaffolds.

Authors:  Yan Lu; Jacquelyn Gervay-Hague
Journal:  Carbohydr Res       Date:  2007-06-09       Impact factor: 2.104

Review 5.  Progress of small molecular inhibitors in the development of anti-influenza virus agents.

Authors:  Xiaoai Wu; Xiuli Wu; Qizheng Sun; Chunhui Zhang; Shengyong Yang; Lin Li; Zhiyun Jia
Journal:  Theranostics       Date:  2017-02-08       Impact factor: 11.556

Review 6.  Development of effective anti-influenza drugs: congeners and conjugates - a review.

Authors:  Jiun-Jie Shie; Jim-Min Fang
Journal:  J Biomed Sci       Date:  2019-10-23       Impact factor: 8.410

Review 7.  Anti-influenza virus agents: synthesis and mode of action.

Authors:  Irene M Lagoja; Erik De Clercq
Journal:  Med Res Rev       Date:  2008-01       Impact factor: 12.944

8.  Preventing Influenza A Virus Infection by Mixed Inhibition of Neuraminidase and Hemagglutinin by Divalent Inhibitors.

Authors:  Xuan Wei; Wenjuan Du; Margherita Duca; Guangyun Yu; Erik de Vries; Cornelis A M de Haan; Roland J Pieters
Journal:  J Med Chem       Date:  2022-05-12       Impact factor: 8.039

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.